New concepts in hypertension: focus on the elderly

Area of Science:

• Gerontology
• Cardiology
• Public Health

Background:

• The global population is aging, leading to a higher prevalence of hypertension in elderly individuals.
• Elderly patients face greater cardiovascular and cerebrovascular risks from hypertension compared to younger populations.
• Systolic hypertension, often due to age-related arterial stiffening, constitutes over 50% of hypertension cases in the elderly.

Purpose of the Study:

• To evaluate the efficacy and safety of antihypertensive therapy in the elderly population.
• To assess the impact of blood pressure reduction on cardiovascular and cerebrovascular outcomes in older adults.
• To determine the cost-effectiveness of hypertension management in the elderly.

Main Methods:

• Analysis of large-scale, controlled, randomized trials on antihypertensive therapy in elderly individuals.
• Review of evidence demonstrating the benefits of blood pressure reduction on morbidity and mortality rates.
• Examination of studies focusing on isolated systolic hypertension in older patients.

Main Results:

• Antihypertensive therapy in the elderly safely and effectively reduces cerebrovascular and cardiovascular morbidity and mortality.
• Treatment benefits extend to decreasing the incidence of stroke, myocardial infarction, and left ventricular failure, even in isolated systolic hypertension.
• Antihypertensive treatment is more cost-effective in the elderly due to higher risks associated with untreated hypertension.

Conclusions:

• Elevated blood pressure management is crucial for reducing adverse cardiovascular and cerebrovascular events in the aging population.
• Antihypertensive therapy offers significant benefits for elderly patients, including those with isolated systolic hypertension.
• Further research is needed to determine optimal antihypertensive agents and treatment thresholds for specific elderly subgroups, such as those with stage I isolated systolic hypertension.